Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Introduction: Ayahuasca is a plant-based decoction native to Amazonia, where it has a long history of use in traditional medicine. Contemporary ritual use of ayahuasca has been expanding throughout the world for mental health purposes, and for spiritual and personal growth. Although researchers have been conducting clinical trials and observational studies reporting medical and psychological benefits, most of these do not report ayahuasca’s immediate or medium-term adverse effects, so these are underrepresented in the literature. With the expansion of ayahuasca ceremonies from their traditional contexts to countries around the world, there is an important public health question regarding the risk/benefit balance of its use. Methods: We used data from an online Global Ayahuasca Survey (n = 10,836) collected between 2017 and 2019 involving participants from more than 50 countries. Principal component analysis was performed to assess group effects. Logistic regression analysis was performed to test for adverse effects associated with history of ayahuasca use, clinical, context of use and spiritual effect variables. Results: Acute physical health adverse effects (primarily vomiting) were reported by 69.9% of the sample, with 2.3% reporting the need for subsequent medical attention. Adverse mental health effects in the weeks or months following consumption were reported by 55.9% of the sample, however, around 88% considered such mental health effects as part of a positive process of growth or integration. Around 12% sought professional support for these effects. Physical adverse effects were related to older age at initial use of ayahuasca, having a physical health condition, higher lifetime and last year ayahuasca use, having a previous substance use disorder diagnosis, and taking ayahuasca in a non-supervised context. Mental health adverse effects were positively associated with anxiety disorders; physical health conditions; and the strength of the acute spiritual experience; and negatively associated with consumption in religious settings. Conclusions: While there is a high rate of adverse physical effects and challenging psychological effects from using ayahuasca, they are not generally severe, and most ayahuasca ceremony attendees continue to attend ceremonies, suggesting they perceive the benefits as outweighing any adverse effects. Knowing what variables might predict eventual adverse effects may serve in screening of, or providing additional support for, vulnerable subjects. Improved understanding of the ayahuasca risk/benefit balance can also assist policy makers in decisions regarding potential regulation and public health responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a global survey involving 10,836 participants, 2.3% reported requiring medical support following ayahuasca use (32).”
From Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol (2025) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, bioavailability of the psychoactive compound DMT varies greatly between and within individuals due to the excessive metabolic first-pass degradation by the MAO enzyme associated with oral ingestion of ayahuasca, which potentially leads to unexpected intensities, overwhelming experiences, and thereby increases psychological risks (48).”
From Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects (2024) · cites this paper as [48]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Nausea and vomiting are common during ayahuasca sessions (32)”
From Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol (2025) · cites this paper as [32]
The cited source says what the claim attributes to it.
In the citing paper
“In a global ayahuasca survey, 42% of participants reported–mostly transient – challenging emotional-cognitive adverse effects (48) such as feeling disconnected or alone (21%).”
From Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects (2024) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Ultra-Brief Screening Scale for Anxiety and Depression: The PHQ–4
Kroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2009) · Psychosomatics · doi:10.1016/s0033-3182(09)70864-3 · Cited by 4,261
Palhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M. M., Pessoa, J. A., Mota-Rolim, S. A., Osório, F. L., Sanches, R., dos Santos, R. G., et al. (2019) · Psychological Medicine · doi:10.1017/s0033291718001356 · Cited by 852
Self-citationOsório, F. D. L., Sanches, R. F., Macedo, L. R., dos Santos, R. G., Maia-de-Oliveira, J. P., Wichert-Ana, L., de Araujo, D. B., Riba, J., Crippa, J. A., & Hallak, J. E. (2015) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2014-1496 · Cited by 488
Sanches, R. F., de Lima Osório, F., dos Santos, R. G., Macedo, L. R. H., Maia-de-Oliveira, J. P., Wichert-Ana, L., de Araujo, D. B., Riba, J., Crippa, J. A. S., & Hallak, J. E. C. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000436 · Cited by 466
Palhano-Fontes, F., Andrade, K. C., Tofoli, L. F., Santos, A. C., Crippa, J. A. S., Hallak, J. E. C., Ribeiro, S., & de Araujo, D. B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118143 · Cited by 454
Self-citationRiba, J., Valle, M., Urbano, G., Yritia, M., Morte, A., & Barbanoj, M. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049882 · Cited by 390 · cited 2×
“75mg/DMT/kg), and high (1mg/DMT/kg) doses of ayahuasca [40, 41], subjects scored active doses higher than a placebo in terms of the Visual Analogue Scales “liking,” and the ayahuasca was well tolerated.”
BackgroundBouso, J. C., González, D., Fondevila, S., Cutchet, M., Fernández, X., Ribeiro Barbosa, P. C., Alcázar-Córcoles, M. Á., Araújo, W. S., Barbanoj, M. J., Fábregas, J. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042421 · Cited by 313 · cited 2×
“[31, 64, 65] and both prospective longitudinal studies, e.”
ResultSelf-citationRiba, J., Rodríguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., Montero, M., Callaway, J. C., & Barbanoj, M. J. (2001) · Psychopharmacology · doi:10.1007/s002130000606 · Cited by 303 · cited 2×
“75mg/DMT/kg), and high (1mg/DMT/kg) doses of ayahuasca [40, 41], subjects scored active doses higher than a placebo in terms of the Visual Analogue Scales “liking,” and the ayahuasca was well tolerated.”
BackgroundNeuropharmacology of N,N-dimethyltryptamine
Carbonaro, T. M., & Gatch, M. B. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.016 · Cited by 268 · cited 8×
“Classical hallucinogens, including DMT [66], bind with 5-HT2A receptors, inducing the release of glutamate, which, theoretically, may eventually lead to convulsions and seizures in neurologically vulnerable individuals.”
BackgroundInfluentialRisk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids.
Gable, R. S. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01652.x · Cited by 244 · cited 4×
“However, this has previously been estimated to occur less frequently than in the general population [48].”
BackgroundInfluential
Research works printed but not linked: 2
- C Sánchez-Avilés, 2015, Ayahuasca: From the Amazon to the global village
- JC Bouso, 2021, Ayahuasca Technical Report.
Cited by
Items 101–122 of 122
Chauhan, A., Ukaigwe, A., & Kumar, S. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197760864.003.0006
Lowe, M. X., Darby, Q. A., Kalcheff-Korn, S., & Jackson, H. (2025) · doi:10.31234/osf.io/sfpqa_v3
The Ghosts of Ayahuasca: Conceptual Limits and Spectral Residues
Glazier, J. W., & O'Donnell, S. J. (2025) · Anthropology of Consciousness · doi:10.1111/anoc.70013
Pesti, I. (2025) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.12576
Psychedelics and Mysticism: Mapping Cultural Approaches
Tiaynen-Qadir, T. (2025) · Springer eBooks · doi:10.1007/978-3-031-98596-6_14
Transe et discernement / Partie 2
Notté, É. (2025) · Journal de l hypnose et de la santé intégrative · doi:10.3917/jhsi.033.0009 · Cited by 1
Gearin, A. K., Suen, C. W. M., & Ng, F. K. Y. (2025) · Mindfulness · doi:10.1007/s12671-025-02690-w
“Many traditional contemplative systems anticipate meditation discomfort, inner turmoil, and other challenges as part of a lengthy, often arduous, path of learning, cultivation, and development (Bouso et al., 2022; Eifring, 2015; Farias et al., 2021; Lin-dahl et al., 2021).”
Predicting and exploring ayahuasca effects: Perception, mind-wandering, and EEG oscillations
Silva-Costa, N., Pessoa, J. A., Andrade, K. C., Mota-Rolim, S. A., Palhano-Fontes, F., de Araújo, D. B., & Wießner, I. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251389563 · Cited by 1
“…(DMT), is regularly consumed by hundreds of thousands of people in religious, shamanic, and therapeutic settings, principally in the Americas and Europe (Bouso et al., 2022; International Center for Ethnobotanical Education Research and Service, 2023; Omágua-Kambeba et al., 2023).”
Toscano, M. O., Civardi, S. C., & Durbano, F. (2025) · Pharmaceutical science. · doi:10.5772/intechopen.1014070
Ayahuasca, DMT, and Mental Health: A Current Review of Scientific Studies
Araújo, D. B., Maia, L. O., Sanchez, T. A., Coelho, N. L. G., & Palhano-Fontes, F. (2026) · Current Addiction Reports · doi:10.1007/s40429-026-00721-7
“%) as the most common side effect, followed by transient psy - chological discomfort, typically mild in controlled environments [17, 18 ].”
Teixeira, P. J., Encantado, J., Amaro, H. D., Veiga, D., de Carvalho, L. L., Alcázar‐Córcoles, M. Á., Hallak, J. E. C., SANTOS, R. G. D., Bouso, J. C., & Kohek, M. (2026) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2026.2631378
Self-citationPost-traumatic stress disorder symptoms following psychedelic use: a naturalistic survey study
Evens, R., Uyar, A., Gosslau, E., Dambeck, F., Repantis, D., Wolff, M., & Lueken, U. (2026) · Psychological Medicine · doi:10.1017/s0033291726103754
“Recentsurveys have shown that characteristics of the acute psychedelics experience, especially psychologically difficult or challenging experiences, can be associated with adverse mental health effects (Bouso et al., 2022; Carbonaro et al., 2016; Evans et al., 2023; Simonsson et al., 2023).”
Bouso, J. C., Andión, Ó., Cantillo, J., Pérez, I. H., Farré, M., Obiols, J. E., & González, D. (2026) · Psychedelics · doi:10.1016/j.psyche.2026.100018
Self-citationBarfoot, S., Luke, D. P., Robinson, O. C., & Evans, J. (2026) · Research Square · doi:10.21203/rs.3.rs-9668424/v1
Rubenstein, E. P. (2026) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2026.v08i04.85868
“Clinical and large observational datasets establish gastrointestinal burden as a frequent feature of conventional ayahuasca administration [26,29].”
Rubenstein, E. P. (2026) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2026.v08i04.85913
Jurlando, C. (2026) · Psychedelics · doi:10.1016/j.psyche.2026.100037
Enfoques terapéuticos y ontológicos en el horizonte psicodélico
Rincón, E. J. C. (2026) · MINKA Revista de la Federación Iberoamericana de Psicodélicos y Enteógenos · doi:10.65504/13
“…experiencias difíciles —como “malos viajes”— durante excursiones espirituales en países con prácticas ancestrales, o en ceremonias realizadas en lugares donde no existe una tradición consolidada (Bouso et al., 2022; Giove, 2022; Kohek et al., 2023; Labate y Cavnar, 2021; Rocha et al., 2023).”
Torales, J. C., O’Higgins, M., Barrios, I., Caycho-Rodríguez, T., Castaldelli-Maia, J. M., & Ventriglio, A. (2026) · Industrial Psychiatry Journal · doi:10.4103/ipj.ipj_489_25
Salud intercultural en Pastaza: regulación del uso de plantas medicinales y de la ayahuasca
Iglesias-Quintana, J. X., Jiménez-Montenegro, J. M., Marfetan-Marfetan, V. D. R., & Piñas-Piñas, L. F. (2026) · Verdad y Derecho. Revista Arbitrada de Ciencias Jurídicas y Sociales. · doi:10.62574/n08gyqka
Uso inadecuado de la ayahuasca y sus impactos en la salud: percepción de consumidores
Illicachi-Erazo, A. M., & Toapanta-Amores, D. A. (2026) · Verdad y Derecho. Revista Arbitrada de Ciencias Jurídicas y Sociales. · doi:10.62574/g9gn9z5t
Psychedelics and psychosis: A systematic review of recent-era studies (1984–2025)
Reis, J. A. S., Ueta, L. Z., Bouso, J. C., Hallak, J. E. C., & SANTOS, R. G. D. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261488575
Self-citation
Metadata
- Authors
- Bouso, J. C., Andión, Ó., Sarris, J. J., Scheidegger, M., Tófoli, L. F., Opaleye, E. S., Schubert, V., & Perkins, D.
- Affiliations
- Universidade de São Paulo (BR)
- The University of Melbourne (AU)
- University of Zurich (CH)
- Universidade Estadual de Campinas (UNICAMP) (BR)
- Universidade Federal de São Paulo (BR)
- Corresponding author
- Perkins, Daniel
- ORCID
- Venue
- PLOS Global Public Health
- Publisher
- Public Library of Science (PLoS)
- Published
- 2022-11-16
- Volume
- 2
- Issue
- 11
- Pages
- e0000438
- ISSN
- 2767-3375 (ISSN-L)
- PMC
- PMC10021266
- OpenAlex
- W4309139242
- Cited by
- 118
- References
- 70
- Citations by year
- 2026: 17 · 2025: 38 · 2024: 40 · 2023: 22 · 2022: 1
- FWCI
- 23.06
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLOS Global Public Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Keywords
- ayahuasca, adverse effects, ayahuasca ceremonies, ritual use, mental health outcomes, physical health effects, vomiting, anxiety disorders, spiritual experience, benefits and risks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.